Publications by authors named "Torsten Christensen"

Claim this Profile
I
Insulin degludec versus insulin glargine in type 1 and type 2 diabetes mellitus: a meta-analysis of endpoints in phase 3a trials.
Jiten Vora, Torsten Christensen, Azhar Rana, Steve C Bain

Diabetes Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding the economic burden of nonsevere nocturnal hypoglycemic events: impact on work productivity, disease management, and resource utilization.
Meryl Brod, Michael Wolden, Torsten Christensen, Donald M Bushnell

Value Health· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-severe nocturnal hypoglycemic events: experience and impacts on patient functioning and well-being.
Meryl Brod, Betsy Pohlman, Michael Wolden, Torsten Christensen

Qual Life Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of non-severe hypoglycemic events on daytime function and diabetes management among adults with type 1 and type 2 diabetes.
Meryl Brod, Torsten Christensen, Donald M Bushnell

J Med Econ· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes.
Jason Yeaw, Won Chan Lee, Michael Lyng Wolden, Torsten Christensen, Danielle Groleau

Diabetes Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes.
Jason Yeaw, Won Chan Lee, Mark Aagren, Torsten Christensen

J Manag Care Pharm· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of nocturnal hypoglycemic events on diabetes management, sleep quality, and next-day function: results from a four-country survey.
Meryl Brod, Torsten Christensen, Donald M Bushnell

J Med Econ· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study.
Li Yang, Torsten Christensen, Fengyu Sun, Jinghua Chang

Value Health· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures.
Meryl Brod, Torsten Christensen, Mette Hammer, Anne K Busk, Donald M Bushnell

Qual Life Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs of fast-acting insulin analogues versus short-acting human insulin for Danish patients with type 2 diabetes on a basal-bolus regimen.
Torsten E Christensen, Jens Gundgaard, Trine Pilgaard

J Med Econ· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of non-severe hypoglycemic events on work productivity and diabetes management.
Meryl Brod, Torsten Christensen, Trine L Thomsen, Donald M Bushnell

Value Health· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining and interpreting responsiveness of the Diabetes Medication Satisfaction measure.
Meryl Brod, Torsten Christensen, Jens Harald Kongsø, Donald M Bushnell

J Med Econ· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measuring the health status burden in hemodialysis patients using the SF-36® health survey.
Aaron S Yarlas, Michelle K White, Min Yang, Renee N Saris-Baglama, Peter Galthen Bech, Torsten Christensen

Qual Life Res· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient treatment satisfaction after switching to NovoMix® 30 (BIAsp 30) in the IMPROVE™ study: an analysis of the influence of prior and current treatment factors.
Meryl Brod, Paul Valensi, Joseph A Shaban, Don M Bushnell, Torsten L Christensen

Qual Life Res· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-life dosage and clinical efficacy of biphasic insulin preparations in patients with type 2 diabetes.
Walid K H Fakhoury, Hartmut Richter, Torsten E Christensen

Adv Ther· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct healthcare costs of patients with type 2 diabetes using long-acting insulin analogues or NPH insulin in a basal insulin-only regimen.
Jens Gundgaard, Torsten E Christensen, Trine Lyager Thomsen

Prim Care Diabetes· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of somatropin for the treatment of short children born small for gestational age.
Torsten Christensen, Andrew Buckland, Anthony Bentley, Christian Djurhuus, Rachael Baker-Searle

Clin Ther· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic control and long-acting insulin analog utilization in patients with type 2 diabetes.
Edith M Heintjes, Trine L Thomsen, Fernie J A Penning-van Beest, Torsten E Christensen, Ron M C Herings

Adv Ther· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of somatropin treatment for short children born small for gestational age (SGA) and children with growth hormone deficiency (GHD) in Sweden.
Torsten Christensen, Carrie Fidler, Anthony Bentley, Christian Djurhuus

J Med Econ· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative research and content validity: developing best practices based on science and experience.
Meryl Brod, Laura E Tesler, Torsten L Christensen

Qual Life Res· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device).
Meryl Brod, Mette Hammer, Torsten Christensen, Suzanne Lessard, Donald M Bushnell

Health Qual Life Outcomes· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological insulin resistance: patient beliefs and implications for diabetes management.
Meryl Brod, Jens Harald Kongsø, Suzanne Lessard, Torsten L Christensen

Qual Life Res· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility values for symptomatic non-severe hypoglycaemia elicited from persons with and without diabetes in Canada and the United Kingdom.
Adrian R Levy, Torsten Lu Christensen, Jeffrey A Johnson

Health Qual Life Outcomes· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education.
Diane Wild, Robyn von Maltzahn, Elaine Brohan, Torsten Christensen, Per Clauson

Patient Educ Couns· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes.
Meryl Brod, Torsten Christensen, Donald Bushnell

Qual Life Res· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis